US Patent 11939382 Bispecific PD-1 and TIGIT binding proteins and uses thereof
Patent 11939382 was granted and assigned to MedImmune, LLC on March, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11939382 Bispecific PD-1 and TIGIT binding proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
